about
Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical RelevancePrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorThe soluble form of the EIAV receptor encoded by an alternative splicing variant inhibits EIAV infection of target cellsCirculating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery diseaseP-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation.Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity.The origins of vertebrate adaptive immunity.Analysis of competition binding between soluble and membrane-bound ligands for cell surface receptors.Soluble IL-2Rα (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in miceCirculating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.Proteome analysis of human aqueous humor.Circulating inflammation markers and risk of epithelial ovarian cancerThe role of soluble common gamma chain in autoimmune disease.A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.Factors associated with inflammation markers, a cross-sectional analysis.Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation.Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role.Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation.Ectodomain shedding of angiotensin converting enzyme 2 in human airway epitheliaDownregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine OsteosarcomaClinical outcomes in patients with ICU-related pancreatitis.Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity.Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2.A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis.Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.MicroRNA Changes in Firefighters.Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
P2860
Q26750970-64BCD97E-47B0-459E-941A-00E007390CF8Q27022976-B1BC62CD-19D5-47A0-80A0-A99342277C04Q27302868-4FAED624-691F-425A-8E0E-4EB5E7AF335FQ28757755-FA04B641-DC9E-4AED-A964-B13FF37DD251Q33843564-27BD7431-1E86-4812-B00B-8A2ED35475D7Q33855420-BAE0C782-6E5F-48D4-9044-4722259910F0Q34058456-AF07FFFF-EF50-4269-9514-E8E01FFA1EB0Q34172091-AC699302-98EB-462A-B854-73DE107D4C29Q34451078-D4275904-49D7-4D37-8834-2C4C67171D86Q34576356-EF6FB45E-A099-4E6E-9D2E-9E642E2838DAQ34735417-DB564BB1-BDAD-4DD3-8C06-1F547CCC90C5Q34949061-3AB639E0-7284-4240-A44E-87EB10F92EF9Q35210780-B5D82973-5140-4F18-9ED1-05BC4D47E0F6Q35616136-883C48F1-76F8-45B1-AA52-E9192EF10223Q35633792-82DD41D3-AE04-49E9-89C6-09906B49FB4AQ35774819-B1BE43AC-BE4E-4304-A2E3-0773F89B79F9Q36088722-FBAABA9B-4798-4396-8BD2-42E0640B2253Q36318136-5714D9E7-1AB6-452C-B830-65098BDA5745Q37194653-DCF2139D-C910-4936-A932-831EAAD99DEDQ37264704-2CA62F6C-7D81-4AF7-9C03-1659E1BD6C1DQ37384979-2DEC5574-513D-4F0C-BA89-20E83E16A5A1Q37394568-5C4D0A12-0F50-475A-BB5F-F221CCE92BA6Q37708821-09F681FC-E8CD-4E93-B853-C4682411C7B8Q42188322-1D8AEA36-C7B1-4C73-9B91-7D261048C81DQ42315822-CDFFCAEC-2C3C-4DEF-8618-281E9824C6B0Q44178755-3619051E-A027-4EE2-B91D-903B839DD20DQ49712575-C65B284E-6FB1-44D8-9A9C-90235AFE3439Q52870661-C73396E4-5C5E-4B53-B07E-C249A8658E93
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Soluble receptors in human disease
@ast
Soluble receptors in human disease
@en
Soluble receptors in human disease
@nl
type
label
Soluble receptors in human disease
@ast
Soluble receptors in human disease
@en
Soluble receptors in human disease
@nl
prefLabel
Soluble receptors in human disease
@ast
Soluble receptors in human disease
@en
Soluble receptors in human disease
@nl
P3181
P1476
Soluble receptors in human disease
@en
P2093
P304
P3181
P407
P577
1998-08-01T00:00:00Z